Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

CCCCCCCC
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in C4 THERAPEUTICS INC

JPMORGAN CHASE & CO holds 4.7M shares of CCCC (C4 THERAPEUTICS INC), worth $20.7M as of 2026-Q2. The position was increased (+47.3% shares). CCCC represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$20.7M

Current Shares

4.7M

Total Value Change

+$20.5M

Total Shares Change

+4.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.7M
+47.3%
$20.7M0.0%$4.67
39
2026-Q1
Increased
3.2M
+541x
$7.6M0.0%$2.95
44
2025-Q4
Decreased
5,945
-32.9%
$11,3550.0%$1.96
0
2025-Q3
Increased
8,858
+92.3%
$19,6640.0%$2.23
20
2025-Q2
Decreased
4,606
-86.6%
$6,5870.0%$1.40
0
2025-Q1
Increased
34,419
+3.0%
$55,0710.0%$1.75
15
2024-Q4
New
33,409
-
$120,2730.0%$3.64
34

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used